NCT03567889 2025-12-17
NeoDREAM
Philogen S.p.A.
Phase 3 Recruiting
Clinical Trials
4 trialsNCT04567420 2025-10-16
DARE
Criterium, Inc.
Phase 2 Recruiting
NCT05456165 2024-12-31
Study of an Individualized Vaccine Targeting Neoantigens in Combination With Immune Checkpoint Blockade for Patients With Colon Cancer
Gritstone bio, Inc.
Phase 2 Withdrawn
NCT00066313 2016-08-24
ZD6474 in Treating Patients With Small Cell Lung Cancer
Sanofi
Phase 2 Completed